Skip to content
Products
Resources
Company
Virtual lab
Keep in contact
Solid tumor
Blood cancer
Pharmacogenetics
Knowledge hub
Pubblications
About us
Virtual lab
Careers
Press hub
Contacts
Products
+
Solid tumor
Blood cancer
Pharmacogenetics
Resources
+
Knowledge hub
Pubblications
Company
+
About us
Virtual lab
Careers
Press hub
Contacts
Virtual lab
Keep in contact
Reserved Area
Publications
Publications
Scientific contributions highlighting the impact of Diatech Pharmacogenetics technologies in diagnostics.
Filter
Year
All years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2008
Product line
All product lines
Easy
Easy PGX
Helix
Microsatelliti
Myriapod
Myriapod NGS
Realquant
Response
×
Remove filters
13.06.2023
Easy PGX
Braf gene mutations characteristics on colorectal cancer patients by Diatech pharmacogenetics instrument: Results at hue central hospital and literature review
31.05.2023
Easy PGX
MSI analysis in patients with GIST with lynch syndrome
29.05.2023
Easy
Transcriptional changes in multiple endocrine organs from lethal cases of COVID-19
16.05.2023
Myriapod
,
Myriapod NGS
Impact of second opinion pathology review in the diagnosis and management of atypical melanocytic lesions: A prospective study of the Italian Melanoma Intergroup (IMI) and EORTC Melanoma Group.
12.05.2023
Easy
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
11.05.2023
Easy PGX
NRAS-mutated oncocytic benign liver lesion in an organ donor: Pitfalls and troubles in frozen section diagnosis and risk assessment
04.05.2023
Easy PGX
Büsra Saruhan., Gastrik kanser hastalar?nda mikrosatellite instabilite durumunun retrospektif de?erlendirilmesi:tek merkez deneyimi
04.05.2023
Easy PGX
,
Myriapod NGS
NTRK gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS.
01.05.2023
Response
Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant Treatment
13.04.2023
Microsatelliti
HER2-low in gastro-oesophageal adenocarcinoma: a real-world pathological perspective
Previous
Page
1
Page
2
Page
3
Page
4
Next